76 results
Page 3 of 4
424B3
it1yqn p0k
9 Jun 21
Prospectus supplement
4:42pm
8-K
EX-99.1
ahitx0
9 Jun 21
Other Events
4:40pm
425
EX-99.1
uzh401vz57 iy65
9 Jun 21
Business combination disclosure
4:38pm
8-K
EX-99.1
t3srw
4 Jun 21
POINT Biopharma Announces First Patients
4:22pm
425
EX-99.1
mpyq95t8 hni
4 Jun 21
Business combination disclosure
4:20pm
8-K
EX-99.1
2svu1w18 nboo
1 Jun 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
4:32pm
425
EX-99.1
pcbmx78
1 Jun 21
Business combination disclosure
4:30pm
CORRESP
i0lqlcu7
3 May 21
Correspondence with SEC
12:00am
S-4/A
EX-10.7
2lo0cdq3s5tp
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.15
dy42zp gj
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
dotv9m0bjjh0x8bb1
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.13
72fgj
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
8-K
EX-99.1
4bu2c6g1i7vmaw
28 Apr 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
5:13pm
425
EX-99.1
92m ecx99jg
28 Apr 21
Business combination disclosure
5:11pm
S-4
EX-10.13
gs4ypaohu3lpzryl8bj
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.7
poeeoe7v 97wn80
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm